Oxford Gene Technology

Oxford Gene Technology (OGT) is a leading global diagnostic genomics company founded in 1995, offering a portfolio of FISH, NGS, and array products for clinical and research use in oncology and rare diseases. The company operates on a partnership model, providing assay development and companion diagnostic services, particularly for haematological malignancies. With products used in over 85 countries and a strong emphasis on customer collaboration, OGT is positioned as a key enabler of precision medicine, leveraging its deep experience in molecular genetics to deliver reliable genomic insights.

Multi-modal genomic analysis platform comprising Fluorescence In Situ Hybridization (FISH), Next-Generation Sequencing (NGS) panels, and microarray technologies for biomarker detection in clinical and research settings.

OGT competes in the genomic diagnostics space against large, diversified players like Illumina, Thermo Fisher, and Agilent, as well as specialized NGS and cytogenetics companies. Its differentiation lies in its focused expertise in hybridization-based technologies (FISH/arrays), deep clinical knowledge in haematology, and a strong partnership-oriented customer support model.